Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (

G. Cancello; P. Maisonneuve; N. Rotmensz; G. Viale; M. G. Mastropasqua; G. Pruneri; P. Veronesi; R. Torrisi; E. Montagna; A. Luini; M. Intra; O. Gentilini; R. Ghisini; A. Goldhirsch; M. Colleoni

doi:10.1093/annonc/mdq072

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (

G. Cancello, P. Maisonneuve, N. Rotmensz, G. Viale, M. G. Mastropasqua, G. Pruneri, P. Veronesi, R. Torrisi, E. Montagna, A. Luini, M. Intra, O. Gentilini, R. Ghisini, A. Goldhirsch, M. Colleoni

Research output: Contribution to journal › Article › peer-review

Abstract

Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients

Original language	English
Pages (from-to)	1974-1981
Number of pages	8
Journal	Annals of Oncology
Volume	21
Issue number	10
DOIs	https://doi.org/10.1093/annonc/mdq072
Publication status	Published - Mar 23 2010

Keywords

Adjuvant therapy
Breast cancer
Prognostic features
Very young women

ASJC Scopus subject areas

Oncology
Hematology

Access to Document

10.1093/annonc/mdq072

Fingerprint Dive into the research topics of 'Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women ('. Together they form a unique fingerprint.

Cite this

Cancello, G., Maisonneuve, P., Rotmensz, N., Viale, G., Mastropasqua, M. G., Pruneri, G., Veronesi, P., Torrisi, R., Montagna, E., Luini, A., Intra, M., Gentilini, O., Ghisini, R., Goldhirsch, A., & Colleoni, M. (2010). Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (. Annals of Oncology, 21(10), 1974-1981. https://doi.org/10.1093/annonc/mdq072

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (. / Cancello, G.; Maisonneuve, P.; Rotmensz, N.; Viale, G.; Mastropasqua, M. G.; Pruneri, G.; Veronesi, P.; Torrisi, R.; Montagna, E.; Luini, A.; Intra, M.; Gentilini, O.; Ghisini, R.; Goldhirsch, A.; Colleoni, M.

In: Annals of Oncology, Vol. 21, No. 10, 23.03.2010, p. 1974-1981.

Research output: Contribution to journal › Article › peer-review

Cancello, G , Maisonneuve, P, Rotmensz, N, Viale, G, Mastropasqua, MG, Pruneri, G , Veronesi, P , Torrisi, R , Montagna, E , Luini, A , Intra, M , Gentilini, O , Ghisini, R, Goldhirsch, A & Colleoni, M 2010, 'Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (', Annals of Oncology, vol. 21, no. 10, pp. 1974-1981. https://doi.org/10.1093/annonc/mdq072

Cancello, G. ; Maisonneuve, P. ; Rotmensz, N. ; Viale, G. ; Mastropasqua, M. G. ; Pruneri, G. ; Veronesi, P. ; Torrisi, R. ; Montagna, E. ; Luini, A. ; Intra, M. ; Gentilini, O. ; Ghisini, R. ; Goldhirsch, A. ; Colleoni, M. / Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (. In: Annals of Oncology. 2010 ; Vol. 21, No. 10. pp. 1974-1981.

@article{f29b4c9900b84777a5f2db44e41353f6,

title = "Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (",

abstract = "Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients ",

keywords = "Adjuvant therapy, Breast cancer, Prognostic features, Very young women",

author = "G. Cancello and P. Maisonneuve and N. Rotmensz and G. Viale and Mastropasqua, {M. G.} and G. Pruneri and P. Veronesi and R. Torrisi and E. Montagna and A. Luini and M. Intra and O. Gentilini and R. Ghisini and A. Goldhirsch and M. Colleoni",

year = "2010",

month = mar,

day = "23",

doi = "10.1093/annonc/mdq072",

language = "English",

volume = "21",

pages = "1974--1981",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "10",

}

TY - JOUR

T1 - Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (

AU - Cancello, G.

AU - Maisonneuve, P.

AU - Rotmensz, N.

AU - Viale, G.

AU - Mastropasqua, M. G.

AU - Pruneri, G.

AU - Veronesi, P.

AU - Torrisi, R.

AU - Montagna, E.

AU - Luini, A.

AU - Intra, M.

AU - Gentilini, O.

AU - Ghisini, R.

AU - Goldhirsch, A.

AU - Colleoni, M.

PY - 2010/3/23

Y1 - 2010/3/23

N2 - Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients

AB - Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients

KW - Adjuvant therapy

KW - Breast cancer

KW - Prognostic features

KW - Very young women

UR - http://www.scopus.com/inward/record.url?scp=77957110787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957110787&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdq072

DO - 10.1093/annonc/mdq072

M3 - Article

C2 - 20332136

AN - SCOPUS:77957110787

VL - 21

SP - 1974

EP - 1981

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 10

ER -